Iovance Biotherapeutics Inc (NASDAQ:IOVA)

25.35
BATS BZX Real-Time Price
As of 12:38pm ET
 +0.41 / +1.64%
Today’s Change
15.88
Today|||52-Week Range
54.21
-45.37%
Year-to-Date
HOOKIPA (HOOK), Merck Collaborate to Treat Head & Neck Cancers
Sep 16 / Zacks.com - Paid Partner Content
Why Iovance Is Up Nearly 11% Today
Sep 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close24.94
Today’s open25.00
Day’s range24.81 - 25.99
Volume46,214
Average volume (3 months)2,912,667
Market cap$3.9B
Data as of 12:38pm ET, 09/27/2021

Growth & Valuation

Earnings growth (last year)-18.13%
Earnings growth (this year)-11.78%
Earnings growth (next 5 years)-19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
EDITEditas Medicine Inc-0.24-0.41%
IBRXImmunitybio Inc+0.35+3.42%
ALLOAllogene Therapeutic...+0.05+0.19%
NKTRNektar Therapeutics+0.43+2.32%
Data as of 12:38pm ET, 09/27/2021

Financials

Next reporting dateNovember 10, 2021
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$259.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Carlos, California

Forecasts